Precigen (PGEN) Preferred Shares Issued (2012 - 2013)

Precigen (PGEN) reported Preferred Shares Issued of $85.6 million for Q2 2013, up 32.89% quarter-over-quarter from $64.4 million in Q1 2013.

Precigen (PGEN) Preferred Shares Issued (2012 - 2013) Analysis & Trends

Precigen (PGEN) has 2 years of Preferred Shares Issued data on file, last reported at $85.6 million in Q2 2013.

Preferred Shares Issued for Q2 2013 came in at $85.6 million, changed N/A year-over-year; the trailing twelve-month figure through Dec 2014 was $85.6 million (down 42.94% YoY), and the FY2025 annual result was -$537000.0, down 100.68% from the prior year.
Preferred Shares Issued climbed to $85.6 million in Q2 2013 per PGEN's latest filing, from $64.4 million in the prior quarter.
Over five years, Preferred Shares Issued peaked at $85.6 million in Q2 2013 and troughed at $25.0 million in Q4 2012.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Preferred Shares Issued (Qtr)
1	Alterity Therapeutics	814,307.08 Bn	814,307.05 Bn	-	-
2	Belite Bio	55,320.00 Bn	55,320.00 Bn	-	-
3	Quantum Biopharma	17,149.72 Bn	17,149.72 Bn	-	-
4	Legend Biotech	3,590.00 Bn	3,589.71 Bn	242.10 Mn	-
5	Akari Therapeutics	1,650.72 Bn	1,650.72 Bn	-	-
6	Evaxion A	1,522.09 Bn	1,522.07 Bn	-	-
7	Psyence Biomedical	229.39 Bn	229.38 Bn	-	-
8	Vertex Pharmaceuticals	113.09 Bn	105.85 Bn	2.59 Bn	-
9	Abivax	90.15 Bn	90.15 Bn	-	-
10	Precigen	1.58 Bn	1.58 Bn	20.69 Mn	-

Download Data